DMOAD developments: present and future

Area of Science:

• Rheumatology and Orthopedics
• Pharmacology and Drug Discovery

Background:

• Osteoarthritis (OA) is the most prevalent form of arthritis, posing a significant healthcare challenge.
• Understanding OA's pathophysiology has identified key therapeutic targets for intervention.

Purpose of the Study:

• To review the progress and potential of disease-modifying osteoarthritis drugs (DMOADs).
• To highlight recent clinical trial findings demonstrating the efficacy of novel OA therapies.

Main Methods:

• Review of current scientific literature and clinical trial data on OA treatments.
• Analysis of newly discovered molecular targets and drug candidates for OA.

Main Results:

• Several new classes of molecules targeting OA pathways are in clinical evaluation.
• Recent clinical trials confirm that blocking key OA mechanisms can slow structural changes in knee OA.

Conclusions:

• Emerging DMOADs represent a new era in OA treatment development.
• These advancements offer the potential for disease modification and a future cure for osteoarthritis.